The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 11, 2020
Filed:
Jul. 17, 2017
Applicant:
Gendiag.exe, S.l., Barcelona, ES;
Inventors:
Eduardo Salas, Barcelona, ES;
José Manuel Soria, Barcelona, ES;
Miroslava Ogorelkova, Barcelona, ES;
Roberto Elosua Llanos, Barcelona, ES;
Joan Vila, Barcelona, ES;
Sergio Castillo Fernandez, Barcelona, ES;
Assignee:
Gendiag.exe, S.L., Barcelona, ES;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C07H 21/04 (2006.01); C12Q 1/6883 (2018.01); C12Q 1/6837 (2018.01); C12Q 1/6827 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); C12Q 1/6827 (2013.01); C12Q 1/6837 (2013.01); C12Q 2521/307 (2013.01); C12Q 2521/319 (2013.01); C12Q 2537/113 (2013.01); C12Q 2565/102 (2013.01); C12Q 2565/501 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01);
Abstract
The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.